Multicenter analysis of the clinical implication of lymphadenectomy for intrahepatic cholangiocarcinoma

Clinical implication and optimal extent of lymphadenectomy for intrahepatic cholangiocarcinoma: multicenter analysis of therapeutic index. - Clinical implication and optimal extent of lymphadenectomy for intrahepatic cholangiocarcinoma: multicenter analysis of therapeutic index.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000048291

Enrollment

280

Registered

2022-07-05

Start date

2022-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intrahepatic cholangiocarcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing surgical resection with lymph node dissection for intrahepatic cholangiocarcinoma between 1 January 2000 and 31 December 2016 at Okayama University Hospital and affiliated institutions will be included.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Assessment of lymph node metastasis and therapeutic index of lymphadenectomy	—

Countries

Japan

Contacts

Public ContactYuzo Umeda

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Department of Gastroenterological Surgery

yuzoumeda@okayama-u.ac.jp086-235-7257

Outcome results